Table 4 Survival parameters - CR versus non CR after ASCT. Patients 61–65 years. Number of patients evaluable for treatment response = 72
Median Overall Survival (Months) (95%CI) | Median Time to New Treatment (Months) (95%CI) | |||||
|---|---|---|---|---|---|---|
CR1 | Non CR2 | P- value | CR | Non CR | P-value | |
Period 13 (N = 32) | 59.8 (41.0–78.5) | 52.1 (8.4–95.8) | P = 0.8 (ns) | 28.7 (5.0.-51.4) | 35.7 (14.9–56.5) | P = 0.8 (ns) |
Period 24 (N = 40) | 75.0 (46.3–102.6) | 50.1 (42.1–68.1) | P = 0.2 (ns) | 56.4 (32.4–80.9) | 29.9 (16.4–39.3) | P = 0.02 |
Period 1 + 2 (N = 72) | 68.5 (51.7–85.4) | 52.3 (48.1–56.1) | P = 0.4 | 43.9 (28.7–59.0) | 31.3 (24.3–37.8) | P = 0.04 |